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The cytoplasmic side of focal adhesions is comprised of large molecular complexes that link transmembrane receptors, such as integrins, to the
actin cytoskeleton and mediate signals modulating cell attachment, migration, proliferation, differentiation, and gene expression. These complexes
are heterogeneous and dynamic structures that are apparent targets of regulatory signals that control the function of focal adhesions. Recent studies
using genetic approaches in invertebrate and vertebrate systems have begun to reveal the structure and function of these complexes in vivo.
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Focal adhesions were first identified by electron micros-
copy by Abercrombie et al. (1971) as electron-dense regions
of the plasma membrane that make intimate contact with the
substratum in cultured cells. This physical interaction allows
cells to communicate with their outside environment and
respond appropriately, leading to cell attachment, migration,
proliferation, differentiation, death, and gene expression. At
molecular level, focal adhesions are formed around a
transmembrane core of an α−β integrin heterodimer, which
binds to a component of the extracellular matrix (ECM) on its
extracellular region, constitutes the site of anchorage of the
actin cytoskeletons to the cytoplasmic side of the membrane,
and mediates various intracellular signaling pathways (Bur-
ridge et al., 1988; Hynes, 2002; Jockusch et al., 1995;
Schwartz et al., 1995). In tissues, focal adhesions do not
display prominent structures like others, such as gap
junctions, tight junctions, desmosome, and hemidesmosome
under electron microscopy. Therefore, some speculated that
focal adhesions were artificial structures found in cells
cultured on rigid surface. Nonetheless, by immunoelectron⁎ Fax: +1 916 734 5750.
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at cell matrix junctions (Fuchs et al., 1997). Because integrins
do not contain actin-binding or enzymatic activities, all of the
structural and signaling events are presumably mediated by
proteins associated with the integrin cytoplasmic tails and
molecules they recruit. Multiple molecular linkages connect-
ing integrins to actin cytoskeletons and mechanisms involving
focal adhesion assembly have been established primarily
based on biochemical and cell culture data (Fig. 1) (Brake-
busch and Fassler, 2003; Dedhar, 2000; DeMali et al., 2003;
Geiger et al., 2001; Hynes, 2002; Martin et al., 2002;
Schwartz et al., 1995; Zamir and Geiger, 2001b). Whether
these linkages and mechanisms represent the events occur in
vivo are under investigation. This review attempts to provide
an overview of newly discovered players and genetic analyses
of molecules in the cytoplasmic side of focal adhesions and
reveals the advantages of using cartilage as a tissue model for
dissecting the architecture and function of vertebrate focal
adhesion complexes.
New molecular components of focal adhesions
There were more than 50 focal adhesion proteins identified
prior to 2001 (Zamir and Geiger, 2001a), and the list of focal
adhesion molecule continues to grow in the last few years.
These molecules can be divided into three groups according to
Fig. 1. A scheme illustrating interactions between several components of focal
adhesions linking integrin receptors to the actin cytoskeleton. The molecules are
not drawn to scale.
Table 1
Focal adhesion proteins
Location Focal adhesion proteins
Extracellular Collagen, fibronectin, heparan sulfate, laminin,
proteoglycan, vitronectin
Transmembrane Integrins 18 α and 8 β (24 combinations in humans),
LAR-PTP receptor, layilin, syndecan-4
Cytoplasmic Structural Actin, α-actinin, EAST, ezrin, filamin, fimbrin,
kindling, lasp-1, LIM nebulette, MENA, meosin,
nexilin, paladin, parvin, profilin, ponsin, radixin,
talin, tensin, tenuin, VASP, vinculin, vinexin
Enzymatic Protein tyrosine kinase: Abl, Csk, FAK, Pyk2, Src
Protein serine/threonine kinase: ILK, PAK, PKC
Protein phosphatase: SHP-2, PTP-1B, ILKAP
Modulators of small GTPase: ASAP1, DLC-1, Graf,
PKL, PSGAP, RC-GAP72
Others: calpain II, PI3-K, PLCγ
Adapters p130Cas, caveolin-1, Crk, CRP, cten, DOCK180,
DRAL, FRNK, Grb 7, Hic-5, LIP.1, LPP, Mig-2,
migfilin, paxillin, PINCH, syndesmos, syntenin,
tes, Trip 6, zyxin
Known focal adhesion components.
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(Table 1). There are excellent reviews on more “senior”
members of focal adhesions, including β1 integrin (Brakebusch
and Fassler, 2005), integrin-linked kinase (Grashoff et al., 2004;
Legate et al., 2006), parvin (Legate et al., 2006; Sepulveda and
Wu, 2006), Src (Frame, 2004), focal adhesion kinase (Avraham
et al., 2000; Mitra et al., 2005; Parsons, 2003), paxillin (Brown
and Turner, 2004; Schaller, 2001), zyxin (Renfranz and
Beckerle, 2002; Wang and Gilmore, 2003), talin/vinculin
(Campbell and Ginsberg, 2004; Critchley, 2004, 2005), tensin
(Lo, 2004), vinexin (Kioka et al., 2002), α-actinin (Otey and
Carpen, 2004), PINCH (Wu, 2004), profilin (Witke, 2004),
PTP1B (Bourdeau et al., 2005), Rho (Burridge and Wenner-
berg, 2004), and ERM family (Bretscher et al., 2002). The more
recently identified molecules include previously undocumented
family members of focal adhesion components, known
molecules, but until recently their subcellular localization
revealed, and newly identified genes. These newcomers are
briefly discussed in this review.
Tensin2, tensin3, and cten
Tensin-related molecules are major contributors to the
expansion of the focal adhesion family. Three additional family
members were recently identified (Chen et al., 2002; Cui et al.,
2004; Lo and Lo, 2002). Human tensin2, tensin3, and cten
genes localize to chromosome 12q13, 7p13, and 17q21,
respectively. The domain structures of tensin (or tensin1),
tensin2, and tensin3 are very similar (Fig. 2). The N-terminal
region displays a PTEN-related protein tyrosine phosphatase
(PTP) domain. The same region contains actin-binding (ABD-
1) and focal adhesion-binding (FAB-N) activities (Chen and Lo,
2003; Lo et al., 1994). The PTP domains of tensin1 and tensin2
are considered to be catalytically inactive due to the lack of aconserved “signature motif,” and although tensin3 does contain
the “signature motif,” its enzymatic activity remains to be
tested. All four members contain the SH2 (Src homology 2) and
PTB (phosphotyrosine-binding) domains at the C-termini,
which also includes the second focal adhesion-binding activity
(FAB-C) (Chen and Lo, 2003). Although the PTB domain
represents a binding module of phosphotyrosine, as implied by
its name, it has been shown that the tensin's PTB domain binds
to integrin β tails independent of tyrosine phosphorylation
(Calderwood et al., 2003). The middle regions of tensins do not
share any sequence homology. Like tensin1, tensin2 also
regulates cell migration (Chen et al., 2002), whereas tensin3
participates in the epidermal growth factor (EGF) signaling
pathway. Upon EGF stimulation, tensin3 binds to EGF receptor
through the SH2 domain and is tyrosine phosphorylated
primarily by Src kinase (Cui et al., 2004). Tensin3 null mice
are growth retarded and die in 3 weeks after birth. Mutant mice
display abnormalities in lung, small intestine, and bone (Chiang
et al., 2005). These phenotypes are similar but less severe than
those of EGF receptor knockout mice (Sibilia and Wagner,
1995; Threadgill et al., 1995), consistent with the idea that
tensin3 is a downstream molecule of the EGF signaling
pathway. Cten, C-terminal tensin like, is somewhat unique to
other tensins. The molecule is much smaller, lacks the
conserved N-terminal regions found in other tensins, and the
tissue expression is relatively restricted to the prostate and
placenta (Lo and Lo, 2002). Recent data suggest that cten may
play a role in preventing prostate cell transformation and
regulating apoptosis (Lo and Lo, 2002; Lo et al., 2005).
Talin2
Talin2 is the second member of the talin family (Monkley et
al., 2001). The amino acid sequences are highly homologous,
and intron/exon boundaries are completely conserved. Talin2
contains a four-point-one ezrin, radixin, moesin (FERM)
Fig. 2. Domain structures of recently identified (A) and commonly found (B) focal adhesion molecules. The numbers shown are the number of amino acids in human
proteins. PTP, PTEN-related protein tyrosine phosphatase domain; ABD, actin-binding domain; SH2, Src homology domain 2; PTB, phosphotyrosine binding; FAB,
focal adhesion binding; C1, protein kinase C conserved region 1; FERM, four-point one, ezrin, radixin, moesin; PH, pleckstrin homology; Pro, proline-rich region;
LIM, lin-11, isl-1, and mec3; PET, prickle espinas, testing; N, nebulin-like repeat; SH3, Src homology domain 3; SAM, sterile alpha motif; START, StAR-related lipid
transfer; ANK, ankyrin repeat; CH, calponin homology.
282 S.H. Lo / Developmental Biology 294 (2006) 280–291domain and the human gene is located at 15q15–21. Due to
much larger introns in talin2, the entire talin2 gene is about 6
times larger than talin1 gene in mammals. Because all the
domains in talin1 are conserved in talin2, they most likely bind
to the same group of molecules. For example, talin2 is shown to
bind to PIP kinase 1γ (Di Paolo et al., 2002) and actin (Senetar
et al., 2004). Nonetheless, there are many potential alternative
splice forms of talin2 and a more restricted expression pattern,suggesting that talin2 may have a unique function in specific
tissues. A talin2 mutant mouse line generated from a gene-
trapped ES clone has been established (Chen and Lo, 2005).
The homozygous mutant mice still expressed the N-terminal
half (1–1295) of talin2 fused to β-galactosidase. Under these
circumstances, it was predicted that deletion of the C-terminal
half of talin2 and in some splice forms the majority of protein
(for example, testis form) would impair the dimerization, and
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located at the deleted C-terminus. In addition, the remaining N-
terminal half might function as a dominant-negative fragment to
elicit a gain of function phenotype in heterozygous and
homozygous mice. Surprisingly, the talin2 mutant mice are
normal and fertile, suggesting that talin2 is not as essential as
talin1 in mice (Chen and Lo, 2005). Alternatively, it is possible,
although less likely, that the N-terminal region is responsible for
all talin2's in vivo function.
Kindlin-1/kindlerin/URP1, kindlin-2/Mig-2, kindlin-3/URP2
The kindlin family is a newly organized focal adhesion
family, which includes kindlin-1/kindlerin/URP1 (UNC-112-
related protein 1), kindlin-2/Mig-2 (mitogen-inducible gene-2),
and kindlin-3/URP2. Kindlins contain a bipartite FERM domain
and a pleckstrin homology (PH) domain. They are the human
homologues ofCaenorhabditis elegans gene UNC 112, which is
an essential component for the recruitment of ILK (Pat-4) to the
muscle attachment structure in worms, and has been implicated
in linking the actin cytoskeleton to the ECM (Rogalski et al.,
2000). Kindlin-1/kindlerin has been linked to Kindler syn-
drome, a rare autosomal-recessive genodermatosis characterized
by bullous poikiloderma with photosensitivity (Jobard et al.,
2003; Siegel et al., 2003). The expression of kindlin-1 is
regulated by transforming growth factor-β1 (Kloeker et al.,
2004) and is often upregulated in lung and colon cancers
(Weinstein et al., 2003). In addition, kindlin-1 binds to integrin β
tails and regulates cell spreading (Kloeker et al., 2004). Mig-2
was initially isolated as a serum-inducible gene (Wick et al.,
1994). Downregulation of Mig-2 in mammalian cells by siRNA
leads to a more rounded cell shape, suggesting a role of Mig-2 in
cell adhesion (Tu et al., 2003) that may represent a common
function for kindling family members. In addition, Mig-2 binds
to migfilin and serves as a docking molecule recruiting migfilin
to focal adhesions. Not much is known about kindlin-3 other
than its expression appears to be confined to the immune
system-related tissues (Weinstein et al., 2003). Kindlin-1,
kindlin-2, and kindlin-3 genes localize to human chromosome
20p12.3, 14q22, and 11q12, respectively.
Migfilin/FBLP-1/Cal
Migfilin/FBLP-1 (filamin-binding LIM protein-1)/Cal
(CSX-associated LIM protein) was isolated independently by
three groups using the yeast two-hybrid screen. Migfilin was
isolated as a molecule binding to Mig-2 that colocalized with
Mig-2 at focal adhesions (Tu et al., 2003). FBLP-1 was
identified by using filamin B (repeats 10–18) as bait (Takafuta
et al., 2003). Cal was isolated also by a yeast two-hybrid screen
using a cardiac homeobox transcription factor, CSX/NKX2.5,
as bait (Akazawa et al., 2004). The human gene is located at
chromosome 1p36. siRNA knockdown experiment shows
migfilin affects cell shape, a phenotype similar to the Mig-2
knockdown (Tu et al., 2003). Overexpression of migfilin
promotes actin stress fiber formation (Akazawa et al., 2004).
Migfilin contains a proline-rich region and three LIM domains.The C-terminal LIM domain binds to Mig-2. In addition,
migfilin interacts with filamin and VASP via its N-terminus and
the proline-rich region, respectively (Wu, 2005). These
interactions may allow migfilin and Mig-2 to link to the actin
cytoskeleton via filamin and regulate the cell shape. Further-
more, migfilin shuttles between focal adhesions and the
nucleus, where it interacts with cardiac transcriptional factor
CSX/NKX2.5 through its LIM domains, and promotes the
transcriptional activity of CSX (Akazawa et al., 2004).
Tes
Tes(tin) was identified as a candidate tumor suppressor. The
human TES gene is located at 7q31 and falls within the fragile
chromosomal region FRA7G, a locus that shows loss of
heterozygosity in many human tumors (Tatarelli et al., 2000).
Tes contains a PET (prickle espinas, testin) domain at N-
terminal region and three LIM domains at the C-terminal half.
Its N-terminal region binds to α-actinin and paxillin, whereas
the LIM domains interact with mena, zyxin, talin, VASP, actin,
and spectrin (Garvalov et al., 2003; Rotter et al., 2005). Tes
overexpression enhances cell spreading and decreases cell
motility (Coutts et al., 2003). Tes knockdown by siRNA leads to
a loss of actin stress fibers (Griffith et al., 2005). The focal
adhesion localization of tes is zyxin dependent and is regulated
by the interaction between the N- and C-terminal halves of tes
(Garvalov et al., 2003). Tes null mice appear to be normal but
are more susceptible to carcinogen induced gastric cancer,
consistent with its proposed role as a tumor suppressor (Drusco
et al., 2005).
Lasp-1
Lasp-1 (LIM and SH3 protein 1) was originally identified as
a phosphoprotein that migrated on SDS–PAGE gels with an
apparent molecular mass of 40 kDa (Chew and Brown, 1987).
The phosphorylation of this protein was enhanced by elevation
of cAMP and the cloning data identified the molecule as lasp-1
(Chew et al., 1998). Lasp-1 contains an N-terminal LIM
domain, two nebulin-like repeats, and a C-terminal SH3 domain
(Li et al., 2004). It is structurally related to lasp-2/LIM nebulette
and also shares the function of binding to the N-terminal of
zyxin through the SH3 domain. In addition, it interacts with
actin filaments in a serine phosphorylation-dependent manner
(Chew et al., 2002). Human lasp-1 gene localizes to chro-
mosome 17q21.
Lasp-2/LIM nebulette
Lasp-2/LIM nebulette was originally identified in silico
(Katoh, 2003) and later as a protein binding to zyxin (Li et al.,
2004) and F-actin (Terasaki et al., 2004). It contains a LIM
domain, three nebulin-like repeats, and a C-terminal SH3
domain. It is a splice variant of nebulette, which is a 105-kDa
sarcomeric protein only expresses in muscle cells. Nebulette
contains 23 nebulin repeats, an SH3 domain, but no LIM
domain. LIM nebulette is expressed in nonmuscle cells (Li et
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terminal of zyxin. The role of LIM nebulette is currently
unknown but is proposed to play a role in the assembly of focal
adhesions similar to the function of nebulette in the assembly of
the sarcomeric Z-disks. The human gene is located at
chromosome 10p12.
DLC1/p122RhoGAP/ARHGAP7
DLC-1 (deleted in liver cancer 1) gene was isolated from a
primary human hepatocellular carcinoma by representational
difference analysis (Yuan et al., 1998). The gene is localized on
chromosome 8p21–22, a region of loss of heterozygosity in a
number of human cancers. Genomic deletion of DLC-1 was
found in many cancer cell lines and tissues. Downregulation of
DLC-1 was also observed in human cancer samples. In addition,
DLC-1 is able to inhibit tumor cell growth in human liver,
breast, and lung cancer (Ng et al., 2000; Yuan et al., 2003,
2004). A rat homologue of the DLC-1, p122RhoGAP, was
cloned as a phospholipase Cδ1-binding protein from a rat brain
library (Homma and Emori, 1995). It contains a RhoGAP
domain in the middle region that enhances the phosphatidyli-
nositol(4,5)-bisphosphate-hydrolyzing activity of PLCδ1. In
addition, there is a SAM (sterile alpha motif) domain at the N-
terminus and a START (StAR-related lipid transfer) domain at
the C-terminus. Overexpression of the C-terminal region of
p122 RhoGAP inhibits the lysophosphatidic acid (LPA)-
induced formation of actin stress fibers and focal adhesions
by inhibiting the GTP-bound-activated form of Rho and leading
to a concomitant increase in intracellular Ca2+ levels (Sekimata
et al., 1999). P122 RhoGAP was found to localize to caveolin
and focal adhesions (Kawai et al., 2004; Yamaga et al., 2004)
and to interact with tensin (Liao, Si, and Lo, unpublished
results). Deletion of DLC1 in mice led to embryonic lethality
(Durkin et al., 2005).
RC-GAP72/ARHGAP24
RC-GAP72 (Rac1/Cdc42-specific GAP with a predicted
molecular mass of 72 kD)/ARHGAP24 was identified by a
bioinformatics search and microscopy-based screen (Lavelin
and Geiger, 2005). It contains a RhoGAP domain near the N-
terminus and enhances GTPase activity of Rac1 and Cdc42 but
not RhoA. The C-terminal region of RC-GAP72 interacts with
actin fibers, focal adhesions, and cell–cell contacts. Over-
expression of RC-GAP72 induces cell rounding with disruption
of actin stress fibers. It is proposed that RC-GAP72 affects
cellular morphology by targeting-activated Cdc42 and Rac1
GTPases to specific subcellular sites, triggering local morpho-
logical changes (Lavelin and Geiger, 2005). Human RC-GAP72
gene is at 4q21.
Genetic analysis in fly
Drosophila melanogaster provides an excellent model
system for studying integrin function and the focal adhesion
complex. This is because integrin-dependent cell adhesion isrequired for proper organization of multiple embryonic and
adult tissues, and also the Drosophila genome is not as
complex as that of vertebrate. There are 5 α (αPS1–5) and 2 β
(βPS and βv) integrin subunits identified in Drosophila,
whereas 18 α and 8 β subunits have been reported in mam-
mals. Drosophila αPS1βPS is a laminin-binding integrin, cor-
responding to vertebrate α3β1, α6β1, and α7β1, whereas
αPS2βPS is an RGD-binding integrin, corresponding to ver-
tebrate α5β1, αVβ1, and α8β1. Almost all null mutations in
PS integrins cause lethality in the embryo of first instar larva
(Bloor and Brown, 1998; Brower, 2003; Bunch et al., 1992).
Two of the phenotypes highlight the contribution of integrin
adhesion: the detachment of the muscles from the epidermis in
null embryos, and the formation of wing blisters in
homozygous somatic clones. As noted above, the pool of
focal adhesion components is smaller in Drosophila than in
vertebrates. For example, Drosophila has one talin, PINCH,
Fak, and tensin gene; whereas two talin, two PINCH, two
Fak, and four tensin genes are present in mouse. The lower
diversity of focal adhesion components will make data inter-
pretation simpler by reducing the potential redundancy and
compensation from other family members, as is often observed
in knockout mice. Therefore, studies in relatively simple organ-
isms such as D. melanogaster have the potential to reveal more
details about the basic, conserved molecular linkages and
mechanisms related to the architecture and function of focal
adhesions.
To identify potential integrin effectors in Drosophila, two
laboratories have performed genetic screens for mutants
displaying wing blisters, an adult phenotype resulting from
the disruption of the integrin-mediated basal junctions that hold
the two wing surfaces together (Prout et al., 1997; Walsh and
Brown, 1998). About 25 new loci were identified. Among them,
the steamer duck (stck) locus encodes PINCH. PINCH null
mutations cause early larval lethality due to defects in muscle
attachment. The mutants hatch but fail to grow. Mutation clones
in wing tissue lead to blister formation. The actin cytoskeleton
was disrupted and detached from integrins adhesion sites,
whereas integrin and ILK (integrin-linked kinase) localization
was not affected in mutants, demonstrating that the proper
localization of integrin and ILK is independent to PINCH but is
not sufficient to stabilize the actin cytoskeleton. On the other
hand, the appropriate localization of PINCH requires integrins
(Clark et al., 2003).
The same screen for potential integrin effectors also
identified another locus, rhea, which corresponds to the single
Drosophila talin (Brown et al., 2002). Talin null embryos
display a failure in germband retraction and strong muscle
detachment phenotypes, which are very similar to integrin
(βPS) null embryos. Clones of mutant cells in the wing do not
attach to the other cell layer of the wing. One of the key
functions of talin is to connect ECM-bound integrins to the actin
cytoskeleton because integrins remain at the cell surface and
localize normally in the absence of talin. Localization of talin to
integrin adhesion sites requires integrins. However, talin is
recruited to gonadal mesoderm by a mechanism unrelated to
integrins.
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mutations in flies cause embryonic lethality and have a muscle
detachment defect. Clones of cells lacking ILK in the adult wing
lead to blister formation (Zervas et al., 2001). These results
indicate that ILK is required to link the actin cytoskeleton to the
integrin sites. However, the protein kinase activity of ILK is not
required for this function because the phenotypes can be fully
rescued by ILK kinase-dead mutant. This is also the case in C.
elegans. ILK (PAT-4) is essential for integrin-mediated adhesion
during muscle development in the C. elegans and kinase dead of
ILK can rescue the lethal phenotype to a normal lifespan
(Mackinnon et al., 2002). On the other hand, the kinase domain,
even without the kinase activity, is required for ILK's normal
function in integrin-mediated attachment, demonstrating that
the main function of ILK is to serve as a structural adaptor in
invertebrates. Interestingly, although ILK binds to β integrin tail
and PINCH, Drosophila ILK localizes to muscle ends in the
absence of integrins or PINCH (Zervas et al., 2001). Therefore,
there must be another mechanism for recruiting ILK to the
adhesion sites.
Mutations in Drosophila tensin are responsible for the
blistery (by) allele mutant, which displays a viable blistered
wing phenotype (Lee et al., 2003; Torgler et al., 2004). Because
the wing blisters in tensin mutant flies appeared shortly after
eclosion and were localized at the distal end of the wings, it was
speculated that the mechanical shear stress from normal motion
of the back legs helps the expansion and flattening of the wings
caused the wing blister. Interestingly, the wing blister phenotype
was rescued by gluing the legs of mutant flies to a glass slide,
just as the wings started to unfold after eclosion (Torgler et al.,
2004). Therefore, tensin is required to stabilize adhesion in the
wing so that it can resist the normal mechanical abrasion
associated with wing flattening after eclosion. In addition, the
genetic approaches also demonstrated that tensin interacts with
integrin and the JNK signaling pathway during wing develop-
ment. The blistered wing phenotype and rate were significantly
enhanced in tensin (by) and integrin (if ), JNK (bsk), or MKK7
(hep) double mutants (Lee et al., 2003). Further experiments
using other mutant flies have revealed the localization of tensin
to integrin adhesion sites requires integrins, talin, and integrin-
linked kinase, but not PINCH (Torgler et al., 2004). It is
worthwhile noting that at amino acid sequence level, Drosoph-
ila tensin is not very similar to vertebrate tensins. The only
conserved regions are the SH2 and PTB domains. Drosophila
tensin is much shorter than tensin1, tensin2, and tensin3. It is
more similar to vertebrate cten, which only shares sequence
homology with the SH2 and PTB domains. Nonetheless, the N-
terminal regions of cten and Drosophila tensin are totally
different. For some time, it was questioned whether this
Drosophila tensin represents the true ortholog of tensin.
Because there is no other gene in Drosophila that looks like
tensin, which localizes to the integrin complex and shares
functional similarity, this is most likely the Drosophila ortholog
of tensin.
Flies lacking Fak56, the only Fak gene in Drosophila, are
viable and fertile (Grabbe et al., 2004), demonstrating that Fak
is not essential for integrin function in adhesion, migration, orsignaling. This is also the case in C. elegans because worms
with a large deletion in the Fak (kin-32) open reading frame or
with RNAi treatment appear to be normal (www.wormbase.
org). The localization of integrin, talin, tiggrin, and actin to
integrin complexes does not require Fak56 (Grabbe et al.,
2004). Interestingly, muscle-specific overexpression of Fak56
resulted in a potent muscle detachment phenotype (Grabbe et
al., 2004), similar to the lack of αPS2 (Brown, 1994). Further
experiments showed that αPS2 integrin remains at the ends of
the detached muscles indicating its dissociation from the
extracellular matrix. The localization of talin and ILK at muscle
attachment sites was not affected by Fak56 overexpression.
These results suggest that Fak56 overexpression does not lead
to the disassembly of the integrin–actin link but results in a
detachment of the plasma membrane via dissociation of the
integrins from the ECM, indicating that Fak56 overexpression
may negatively regulate integrin ligand-binding affinity
(Grabbe et al., 2004). It will be interesting to test whether the
kinase activity of Fak56 can account for the overexpression
phenotype. Because Fak56 and kin-32 are the only Fak genes in
Drosophila and C. elegans, it is clear that Fak is not required for
integrin-mediated adhesion or signaling in fly and nematode.
Similarly, vinculin mutant flies are viable and fertile (Alatortsev
et al., 1997), although vinculin (DEB-1) mutant worms were
paralyzed and had disorganized muscle (Barstead and Water-
ston, 1991). Nonetheless, both genes play more critical roles in
vertebrates: both Fak and vinculin knockout mice are
embryonic lethal (Furuta et al., 1995; Xu et al., 1998).
In summary, analyses of these fly mutants have confirmed
the involvement of several cytoplasmic proteins, including talin,
ILK, PINCH, and tensin, in integrin-dependent adhesion.
Although not yet completed, the localization studies in various
mutant flies have revealed that (1) integrin is required for the
proper localization of talin, PINCH, tensin, and actin filament,
but not ILK; (2) talin is required for tensin and actin filaments,
but not integrin; (3) ILK is required for tensin and actin
filaments; and (4) PINCH is not required for tensin and ILK.
Meanwhile, several surprises were observed. ILK apparently is
essential for integrin function, but the kinase activity is not
required. Two major focal adhesion molecules, focal adhesion
kinase and vinculin, which are essential for mouse develop-
ment, are dispensable in fly. Tensin null flies only display a
viable wing blister phenotype. These results show the
discrepancy between flies and mice, and that some focal
adhesion molecules gain more critical function in vertebrates.
The systematic use of genetic approaches to characterize the
involvement of the focal adhesion molecules in fly should lead
to the identification of the essential molecules required and
provide the mechanism in assembly and regulating focal
adhesions in Drosophila.
Genetic analysis in mouse
Ablation of focal adhesion genes leads to various phenotypes
during development, ranging from apparently normal mice to
early embryonic lethality. There are excellent reviews discuss-
ing the ECM and integrin knockout mice (Bouvard et al., 2001;
Table 2
Focal adhesion gene knockout mice
Gene Phenotypes Reference
Abl L, neonatal Lymphopenia Tybulewicz et al. (1991)
Caveolin-1 V, F Loss of caveolae,
vascular and pulmonary
abnormalities
Drab et al. (2001);
Razani et al. (2001)
Cdc42 L, E6.5 Ectoderm defect Chen et al. (2000)
Csk L, E9–10 Neural tube defect Imamoto and
Soriano (1993)
DLC1 L, E10.5 Defects in the neural
tube, brain, heart, and
placenta







Saotome et al. (2004)
Fak L, E9.5 Mesodermal defect Furuta et al. (1995)












Lanier et al. (1999)




Doi et al. (1999)
p130Cas L, E12.5 Heart and blood vessel
defects
Honda et al. (1998)
Paladin L Neural tube closure defect Luo et al. (2005)
Parvin-β V, F No apparent phenotype;
parvin-α upregulated
ELSO 2005 abstract
Parvin-γ V, F No apparent phenotype Chu et al. (2006)
Paxillin L, E8.5 Mesodermal defect Hagel et al. (2002)






Li et al. (2005);
Liang et al. (2005)
PINCH2 V, F No apparent
developmental defect,
PINCH1 upregulated
Stanchi et al. (2005)
Profilin 1 L No detectable
mutant blastocysts
Witke et al. (2001)
PTP1B V, F Hypersensitive to insulin
and resistant to obesity
Elchebly et al. (1999);
Klaman et al. (2000)





Guinamard et al. (2000);
Okigaki et al. (2003);
Yu et al. (2005)
Rac1 L, E9.5 Abnormalities in three
germ layers
Sugihara et al. (1998)
Radixin V, F Mild liver injury in
older mice
hyperbilirubinemia
Kikuchi et al. (2002)
Src V Osteopetrosis Soriano et al. (1991)
Talin1 L, E8.5 Incomplete gastrulation Monkley et al. (2000)
Talin2* V, F No apparent
developmental phenotype
Chen and Lo (2005)
Table 2 (continued)
Gene Phenotypes Reference
Tensin1 V, F Kidney and muscle
regeneration defects
Ishii and Lo (2001);
Lo et al. (1997)
Tensin3 L,
postnatal
Growth retardation Chiang et al. (2005)
Testin V, F No apparent phenotype,
higher susceptibility to
induced carcinogenesis






Hauser et al. (1999);
Massberg et al. (2004)
Vinculin L, E8–10 Heart and brain defect Xu et al. (1998)
Zyxin V, F No apparent phenotype Hoffman et al. (2003)
V indicates viable; F, fertile; L, lethal.
* Not a complete knockout, see text.
286 S.H. Lo / Developmental Biology 294 (2006) 280–291Hynes, 1996). Here, we focus on the mice carrying mutations in
cytoplasmic components of focal adhesions (Table 2). By now,
we have learned that it is difficult to “predict” the phenotypes
prior to generating mutant mice, but generally they range from
embryonic lethal to apparently normal with mild defects.
Knockout animals of ILK, talin1, Fak, Csk, PINCH1, vinculin,
p130Cas, paxillin, DLC1, Cdc42, Rac1, and paladin die at
various stages during embryogenesis, reflecting the critical
function of these genes in cell adhesion and migration during
embryogenesis. Zyxin, Tyk2, Tes, moesin, talin2, and parvin-
beta null mice were normal and fertile. Only very mild abnor-
malities were found in mice lack of MENA, VASP, and radixin.
Molecules with adult phenotypes are Src, tensin1, tensin3, and
ezrin. Generally, if the gene has no other known family member,
it is required for development and survival. If the gene is a
member of a family, one member tends to be more critical than
the other(s). For example, in the cases of Fak versus Tyk2,
PINCH1 versus PINCH2, and talin1 versus talin2, knockout of
the former gene results in a more severe phenotype than that of
the later. It seems reasonable because other members may
compensate or have overlapping function, although this is appa-
rently not due to the upregulation of gene expression in most
cases.
It is clear that a gene is not essential for the development of a
specific tissue/organ, if the gene is eliminated and the tissue still
develops normally. The question is why the animals do not need
the gene. As mentioned, overlapping functions and compensa-
tion by other family members or related molecules are two
apparent possibilities. On the other hand, it is strange that an
expressed gene has no unique function in an animal. Mutant
mice are routinely examined for the gross morphology and
histology of major tissues/organs. Many other functions, such as
sensory systems, are not routinely analyzed. For example, it is
later found that VASP−/− mice were more sensitive to noise
(Schick et al., 2004). One other possibility is that these “no
phenotype” genes may play roles involving in aging, repair,
regeneration, or defense processes, which are not often occurred
in most experimental setups. This is true for tyk2, tensin1, and
tes mice. When tyk2 null mice were fed with high-fat diet, the
mutant mice had higher obesity and insulin resistance (Yu et al.,
Fig. 3. Histological appearance of the mouse growth plate.
287S.H. Lo / Developmental Biology 294 (2006) 280–2912005). In addition to kidney defects (Lo et al., 1997), the incident
of central nuclei was significantly higher in tensin1 skeletal
muscle and the regeneration process of damagedmuscle induced
by cardiotoxin was severely delayed (Ishii and Lo, 2001). Tes
null mice were more susceptible to N-nitrosomethyl-benzyla-
mine (NMBA)-induced carcinogenesis (Drusco et al., 2005).
This is consistent with tes' proposed role as a tumor suppressor. I
am convinced that with the generation of compound gene
knockout mice, systematic analysis of all expression tissues in
various conditions, sooner or later many of the undetected
phenotypes will be revealed.
From the analyses of the null mice, we have learned that
some targeted genes are essential for embryonic development,
some are important for specific tissues, and some appear
dispensable. These studies are very informative in terms of the
function of each individual gene. However, because of the early
lethality and/or defects in various tissues, it is difficult to
establish a functional linkage and the relationships among focal
adhesion molecules from these data. It will require other
approaches, for example, the systematic analysis of a specific
mutant tissue in constitutive or conditional knockout mice to
dissect the functional network of these molecules in vivo. To
this end, the cartilage may provide an excellent tissue model
because chondrocytes, the primary cell type of cartilage, are
completely surrounded by ECMs, they form functional and
histological distinct zones in the growth plate, and cartilage
development is not essential for the embryonic survival.
Cartilage as a tissue model for analyzing focal adhesion
molecules
The skeleton is essentially developed through two mechan-
isms and both involve the transformation of a preexisting
mesenchymal tissue into bone tissue. The direct conversion of
mesenchymal cells into flat skull bones is called intramem-
branous ossification. The other mechanism to build bones is
endochondral ossification, which involves a two-stage process
in which mesenchymal cells differentiate into cartilage that is
later replaced by bone. Cartilage is the blueprint for subsequent
bone morphogenesis, the location of tendon and ligament
insertions, and morphogenesis of the joints. During endochon-
dral bone development, chondrocytes form the growth plate, in
which several zones are established (Fig. 3). At the top of
growth plate, round chondrocytes no longer proliferate rapidly
and are called resting zone, which is followed by orderly
columns of proliferating chondrocytes (proliferating zone). The
proliferating cells then stop proliferating and form the
hypertrophic zone, which is the primary engine of bone growth.
The hypertrophic chondrocytes undergo apoptosis and the
deposited matrix provides a scaffold for osteoblasts and blood
vessels invasion (invasion zone). The cartilage development is
well regulated by local signals, including Wnt, Hedgehog,
fibroblast growth factor, transforming growth factor-β, and
bone morphogenetic protein families, and by transcriptional
factors such as Sox and Runx families (Ballock and O'Keefe,
2003a; de Crombrugghe et al., 2001; Kronenberg, 2003;
Leinders-Zufall et al., 2004).On the other hand, chondrocytes are completely surrounded
by ECM with no cell–cell contacts. Therefore, the interactions
between chondrocytes and ECMs may regulate, in concert with
factors mentioned above, their proliferation and differentiation.
Likewise, ECM receptors (mainly integrins) on chondrocytes
may modulate cell adhesion and the assembly of ECM
molecules in cartilage. The ECM network is dynamic and
coordinated with proliferation stages. When resting chondro-
cytes switch to prehypertrophic chondrocytes, the synthesis of
ECM molecules is also switched. Whereas proliferating
chondrocytes express and secrete type II collagen, hypertrophic
chondrocyte produce type X collagen. Chondrocytes express a
characteristic set of integrins including receptors for collagen II
(integrins α1β1, α2β1, and α10β1), fibronectin (integrins
α5β1, αvβ3, and αvβ5), and laminin (integrin α6β1) and other
focal adhesion molecules such as ILK, talin, tensin, vinculin,
Fak, tyk2, and paxillin (Vinall et al., 2002). It is not surprising
that mutations in these genes may lead to human diseases. For
example, collagen II mutations cause a spectrum of chondro-
dysplasias ranging from mildly affected patients of normal
stature and premature osteoarthritis to severely affected patients
with short stature and the lethal forms of achondrogenesis type
II (Ballock and O'Keefe, 2003b).
From the available constitutive and conditional knockout
mouse models, the involvements of several ECM and focal
adhesion components in cartilage development can be defined.
For ECM components, collagen II null mice die around birth
with disorganized cartilage and lack of growth plate (Aszodi et
al., 1998). Collagen IX null mice show degenerative changes of
articular cartilage (Fassler et al., 1994). On the other hand,
chondrocyte-specific knockout of fibronectin, or tenascin-C,
matrilin1/2/3, cartilage oligomeric matrix protein (COMP) null
mice show no bone defect (Aszodi et al., 1999, 2003; Brandau
et al., 2002; Forsberg et al., 1996; Saga et al., 1992; Svensson et
al., 2002). For integrin receptors, loss of integrin α1, α2, α6,
αv, β3, or β5 expression in mice shows no skeletal phenotypes
(Bouvard et al., 2001). Loss of α10 integrin expression leads to
moderate dysfunction of the growth plate (Bengtsson et al.,
2005). The mutant mice had a normal lifespan and were fertile
but developed a growth retardation of the long bones, a
288 S.H. Lo / Developmental Biology 294 (2006) 280–291disturbed columnar arrangement of chondrocytes, an abnormal
chondrocyte shape, and a reduced proliferation. Loss of β1
integrin in chondrocytes results in a severe chondrodysplasia,
characterized by the complete lack of chondrocyte columns in
growth plates, distorted collagen fibrillar network in the
cartilage matrix, and reduced proliferation (Aszodi et al.,
2003). For focal adhesion molecule binding to integrin
cytoplasmic tails, ILK conditional knockout mice also develop
chondrodysplasia and die at birth (Grashoff et al., 2003;
Terpstra et al., 2003). The proliferative and hypertrophic zones
in mutant growth plate were reduced and the column was
slightly disorganized. Tensin3 null mice are growth retarded and
die before weaning. The mutant long bones were shorter but the
resting zone was larger in mutant growth plate (Chiang et al.,
2005). However, conditional knockout mice from another
integrin-binding protein, Fak, show no bone defect (Chen, Liao,
and Lo, unpublished results), despite the fact that Fak null
constitutive knockouts are embryonic lethal. These results
support the idea that focal adhesions are structurally and
functionally heterogeneous. It is clear that chondrocyte-specific
ECM, collagen II, is required for overall cartilage development
and is essential for growth plate formation. Integrin β1 is
essential for chondrocyte column organization to modulate
other zone formation. ILK regulates proliferative and hypertro-
phic zone development, whereas tensin3 may regulate the
transition process from resting to proliferative zones. From the
severity of the phenotype, the degree of involvement could be
established as collagen II > integrin β1 > ILK > tensin3. With
this approach, we should be able to define the singular and
collaborative roles of focal adhesion molecules in cartilage
development and function in the near future.
Conclusions and future directions
Three decades after the discovery of focal adhesions, we
have learned a lot of this dynamic organelle. Numerous
associated molecules, molecular linkages connecting ECM to
the actin cytoskeleton, and mechanisms that regulate signal
transduction pathways and modulating focal adhesion assembly
have been identified. With a growing number of null mice
available, the physiologic role of each individual focal adhesion
molecule is demonstrated. The future challenges include
determination of how these molecules work together as a
complex, and how focal adhesion heterogeneity contributes to
various biological responses in different tissues. Genetic
analysis of the less intricate focal adhesion systems in
invertebrates will lead to discovery of the minimal set of
conversed components necessary to form and regulate focal
adhesions. In mice, the combination of multiple and conditional
knockout approaches will provide a powerful tool in dissecting
the focal adhesion network in vertebrates.
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